Dishman Carbogen Amcis Ltd. logo

Dishman Carbogen Amcis Ltd. (DCAL)

Market Closed
10 Aug, 10:00
XNSE XNSE
188. 30
-4.74
-2.4554%
38.26B Market Cap
- P/E Ratio
0.8% Div Yield
207,160 Volume
- Eps
193.04
Previous Close
Add Transaction
Day Range
187.33 197.89
Year Range
128.5 321.95
Want to track DCAL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DCAL closed today lower at ₹188.3, a decrease of -2.4554% from yesterday's close, completing a monthly increase of 6.9886% or ₹12.3. Over the past 12 months, DCAL stock lost -24.3167%.
DCAL is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Dishman Carbogen Amcis Ltd. has completed 2 stock splits, with the recent split occurring on May 02, 2016.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

DCAL Chart

People also search for

Syngene International Ltd.
402.6
-0.2725%
Doms Industries Ltd.
2,250.1
-0.4645%
Rainbow Children's Medicare Pvt. Ltd.
1,538.6
-1.1627%
Medplus Health Services Ltd.
686.3
-1.9921%
Marksans Pharma Ltd.
271.45
-0.8764%

Dishman Carbogen Amcis Ltd. (DCAL) FAQ

What is the stock price today?

The current price is ₹188.30.

On which exchange is it traded?

Dishman Carbogen Amcis Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is DCAL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 38.26B.

Has Dishman Carbogen Amcis Ltd. ever had a stock split?

Dishman Carbogen Amcis Ltd. had 2 splits and the recent split was on May 02, 2016.

Dishman Carbogen Amcis Ltd. Profile

Biotechnology Industry
Healthcare Sector
Dr. Himani S. Dhotre CEO
XNSE Exchange
Y1R03Y104 CUSIP
India Country
1,132 Employees
12 Sep 2019 Last Dividend
2 May 2016 Last Split
- IPO Date

Overview

Dishman Carbogen Amcis Limited is an established entity in the pharmaceutical sector, providing an extensive range of contract research and manufacturing services on a global scale. With operations spanning both India and international markets, the company facilitates the pharmaceutical industry through two major segments: Contract Research and Manufacturing Services, and Marketable Molecules. Since its inception in 1983, Dishman Carbogen Amcis has grown into a reputable provider headquartered in Ahmedabad, India. It stands today as a significant subsidiary of Adimans Technologies LLP, exemplifying its strength and reliability in the pharmaceutical and chemical manufacturing domain.

Products and Services

The offerings of Dishman Carbogen Amcis Limited encompass a wide array of products and services significant to the pharmaceutical and cosmetic industries, among others. Here’s a detailed look at their varied portfolio:

  • Bulk Drugs, Active Pharmaceutical Ingredients (APIs), and Highly Potent APIs: These are the core ingredients for various medications, with Dishman Carbogen Amcis specializing in their development and manufacturing. They cater to the pharmaceutical industry's need for high-quality foundational components for drug production.
  • Phase Transfer Catalysts, Quaternary Ammonium Compounds, Phosphoranes, Wittig Reagents: Essential for various chemical reactions and syntheses, these specialized chemicals play crucial roles in the manufacture of complex pharmaceutical products, demonstrating Dishman Carbogen Amcis’s capability in producing specialty chemicals.
  • Vitamin D Products and Analogues: The company has carved out a niche in synthesizing Vitamin D products and their analogues, catering to both the pharmaceutical and nutraceutical markets. This includes the manufacture of cholesterol and lanolin-related products, which are precursors in the synthesis of Vitamin D.
  • Hand and Body Wash, Sanitizers, Antiseptics, Disinfectant Formulations: Addressing the demand for hygiene and sanitization products, Dishman Carbogen Amcis offers a range of personal care and antiseptic products, adhering to the highest standards of quality and efficacy.
  • Fine Chemicals: These chemicals are utilized in a variety of applications across different sectors, including pharmaceutical, cosmetic, and other industrial uses. Their production showcases the company’s versatility and competence in handling diverse chemical syntheses.
  • Generic Products: Dishman Carbogen Amcis also deals in the production of generic pharmaceutical products, providing cost-effective alternatives to brand-name medications without compromising quality or effectiveness.

Contact Information

Address: Dishman Corporate House
Phone: 91 27 1742 0102